NO994015L - Gelavleveringsmidler for anticellulære proliferative midler - Google Patents

Gelavleveringsmidler for anticellulære proliferative midler

Info

Publication number
NO994015L
NO994015L NO994015A NO994015A NO994015L NO 994015 L NO994015 L NO 994015L NO 994015 A NO994015 A NO 994015A NO 994015 A NO994015 A NO 994015A NO 994015 L NO994015 L NO 994015L
Authority
NO
Norway
Prior art keywords
agents
gel delivery
antiproliferative
proliferative
anticellular proliferative
Prior art date
Application number
NO994015A
Other languages
English (en)
Norwegian (no)
Other versions
NO994015D0 (no
Inventor
Richard E Jones
Keith Washco
George Trager
Kathleen V Roskos
Richard Maskiewicz
Original Assignee
Matrix Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Pharma filed Critical Matrix Pharma
Publication of NO994015D0 publication Critical patent/NO994015D0/no
Publication of NO994015L publication Critical patent/NO994015L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO994015A 1997-02-20 1999-08-19 Gelavleveringsmidler for anticellulære proliferative midler NO994015L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/803,128 US6630168B1 (en) 1997-02-20 1997-02-20 Gel delivery vehicles for anticellular proliferative agents
PCT/US1998/003107 WO1998036776A2 (en) 1997-02-20 1998-02-19 Gel delivery vehicles for anticellular proliferative agents

Publications (2)

Publication Number Publication Date
NO994015D0 NO994015D0 (no) 1999-08-19
NO994015L true NO994015L (no) 1999-10-15

Family

ID=25185657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994015A NO994015L (no) 1997-02-20 1999-08-19 Gelavleveringsmidler for anticellulære proliferative midler

Country Status (12)

Country Link
US (4) US6630168B1 (de)
EP (1) EP0971745B1 (de)
JP (1) JP2001512487A (de)
KR (1) KR100611137B1 (de)
CN (1) CN1212154C (de)
AT (1) ATE308996T1 (de)
AU (1) AU746938B2 (de)
CA (1) CA2281919A1 (de)
DE (1) DE69832266T2 (de)
NO (1) NO994015L (de)
NZ (1) NZ337875A (de)
WO (1) WO1998036776A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
US6040330A (en) * 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
CA2445763A1 (en) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
CA2456746A1 (en) * 2001-08-20 2003-02-27 Transave, Inc. Method for treating lung cancers
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
NZ531460A (en) * 2001-10-19 2005-05-27 Idexx Lab Inc Controlled release - over at least 4-15 days - of injectable compositions comprising a lipophilic counterion such a saturated or unsaturated C10-C18 fatty acid
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
AU2003302314A1 (en) * 2002-08-02 2004-07-09 Transave, Inc. Platinum aggregates and process for producing the same
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
WO2005051456A2 (en) * 2003-11-13 2005-06-09 Alza Corporation Composition and apparatus for transdermal delivery
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
US20070065522A1 (en) * 2004-03-18 2007-03-22 Transave, Inc. Administration of high potency platinum compound formulations by inhalation
CA2559722A1 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
WO2005112957A1 (en) * 2004-05-21 2005-12-01 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
US7854943B2 (en) 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
CA2570599C (en) * 2004-06-24 2012-03-27 Idexx Laboratories, Inc. Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7858115B2 (en) 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
JP5735724B2 (ja) * 2004-11-08 2015-06-17 インスメッド， インコーポレイテッド 腹腔内投与される脂質ベースの白金化合物製剤を用いた、癌の治療方法
US20060141040A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US20070190182A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
US20070190180A1 (en) * 2005-11-08 2007-08-16 Pilkiewicz Frank G Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
WO2007056236A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
US20070122350A1 (en) * 2005-11-30 2007-05-31 Transave, Inc. Safe and effective methods of administering therapeutic agents
EP2012706A4 (de) * 2006-04-20 2013-02-13 Transport Pharmaceuticals Inc Pharmazeutische formulierungen für iontophoretische methotrexatfreisetzung
CA2883703C (en) 2012-09-04 2021-10-19 Eleison Pharmaceuticals, Llc Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
EP3079668A1 (de) 2013-12-09 2016-10-19 Durect Corporation Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
US9763892B2 (en) 2015-06-01 2017-09-19 Autotelic Llc Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods
CA2980007C (en) * 2015-09-18 2023-05-23 Huntsman Petrochemical Llc Poly(vinyl caprolactam) kinetic gas hydrate inhibitor and method for preparing the same
WO2020081148A1 (en) * 2018-10-16 2020-04-23 US Nano Food & Drug INC Intratumor injection formulation
IN202121042020A (de) * 2021-09-17 2023-03-24

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888995A (en) * 1968-07-19 1975-06-10 Syntex Corp Fatty alcohol-propylene glycol vehicle
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
US4619913A (en) 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
JPS6219528A (ja) 1985-07-16 1987-01-28 Kurorera Kogyo Kk 制癌剤
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
JPH0730029B2 (ja) * 1986-09-08 1995-04-05 株式会社クラレ １−置換アザシクロヘプタン−２−オン及びこれを含有する経皮投与用薬剤
DE3631413A1 (de) 1986-09-16 1988-03-24 Knoll Ag Therapeutisches system zur lokalen applikation von pharmawirkstoffen
US5719197A (en) 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5051257A (en) 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system
CA2061566C (en) 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
GB9310049D0 (en) 1993-05-12 1993-06-30 Cancer Res Campaign Tech Growth factor effects
AU681231B2 (en) * 1993-12-29 1997-08-21 Intarcia Therapeutics, Inc. Methods and compositions for the treatment of a host with a cellular proliferative disease
DK0754032T3 (da) * 1994-04-08 2002-04-02 Atrix Lab Inc Flydende frigivelsessammensætninger
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
US5567420A (en) * 1994-11-16 1996-10-22 Mceleney; John Lotion which is temporarily colored upon application
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
WO1998026771A1 (en) 1996-12-17 1998-06-25 Lidak Pharmaceuticals Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
US5993856A (en) 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6630168B1 (en) * 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents

Also Published As

Publication number Publication date
AU746938B2 (en) 2002-05-09
ATE308996T1 (de) 2005-11-15
CN1212154C (zh) 2005-07-27
DE69832266T2 (de) 2006-08-03
EP0971745B1 (de) 2005-11-09
US6630168B1 (en) 2003-10-07
WO1998036776A3 (en) 1998-11-26
NZ337875A (en) 2001-09-28
WO1998036776A2 (en) 1998-08-27
CA2281919A1 (en) 1998-08-27
CN1251045A (zh) 2000-04-19
EP0971745A2 (de) 2000-01-19
US6669958B1 (en) 2003-12-30
US20040131646A1 (en) 2004-07-08
KR100611137B1 (ko) 2006-08-10
JP2001512487A (ja) 2001-08-21
AU6658398A (en) 1998-09-09
KR20000075543A (ko) 2000-12-15
HK1026142A1 (en) 2000-12-08
DE69832266D1 (de) 2005-12-15
US20040076679A1 (en) 2004-04-22
NO994015D0 (no) 1999-08-19

Similar Documents

Publication Publication Date Title
NO994015L (no) Gelavleveringsmidler for anticellulære proliferative midler
NO20002280D0 (no) Distribuert radiotelefon for bruk i kjøretøy
DK0782855T3 (da) Nimesulid til ekstern anvendelse
IT1291233B1 (it) Procedimento per sterilizzare terreni e relativa attrezzatura.
EP1247835A4 (de) Gummi, vernetzbare gummizusammensetzung und vernetzbares objekt
IL132115A0 (en) Drug preparations for treating sexual dysfunction
SE9904377D0 (sv) Pharmaceutical combinations
DE69700983D1 (de) Ligandgerichtete enzyme-prodrug therapie
TR200103219T2 (tr) Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
NO306292B1 (no) Triaryletylenderivater for anvendelse innen terapi
ES1023443Y (es) Cuna perfeccionada.
ITTO980718A0 (it) Corpo portante per dispositivi tensionatori, in particoalre di cinghie di trasmissione.
WO1999024052A3 (en) Use of protein h as cytostatic agent
IT241603Y1 (it) Dispositivo mobile su ruote e cingoli, di ripresa e di visione, edi illuminazione.
ES1037483Y (es) Dispositivo movil perfeccionado para el tratamiento de arboles y plantas en fumigaciones, tratamientos antiplagas, limpiezas y similares.
ITMI960640A1 (it) Composizioni veterinarie a base di antibatterici per uso intramam- mario
ES1037396Y (es) Poste extensible perfeccionado, para cartolas de camiones.
ITMO990041A0 (it) Sollevatore per ruote di veicoli e metodo per l'impiego dello stesso.
MX9702042A (es) Piridinas sustituidas por 2-arilo.
UA67058A (en) Composition for treating periodontitis
ES1044603Y (es) Preservativo perfeccionado.
BR7603086U (pt) Carroceria versátil dotada de plataforma móvel
ES1029515Y (es) Cuna perfeccionada.
ES1035873Y (es) Dispositivo movil para el tratamiento de arboles, y plantas aplicable en fumigaciones, tratamientos antiplaga, limpiezas y similares.
IT241921Y1 (it) Veicoli semoventi cingolati e gommati.